Literature DB >> 31632658

Prophylactic Antibiotics in Cirrhosis: Are They Promoting or Preventing Infections?

Guadalupe Garcia-Tsao1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31632658      PMCID： PMC6784797          DOI： 10.1002/cld.819

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  17 in total

1.  Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.

Authors:  Javier Fernández; Juan Acevedo; Reiner Wiest; Thierry Gustot; Alex Amoros; Carme Deulofeu; Enric Reverter; Javier Martínez; Faouzi Saliba; Rajiv Jalan; Tania Welzel; Marco Pavesi; María Hernández-Tejero; Pere Ginès; Vicente Arroyo
Journal:  Gut       Date:  2017-08-28       Impact factor: 23.059

2.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

Review 3.  Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Authors:  Anat Gafter-Gvili; Abigail Fraser; Mical Paul; Liat Vidal; Theresa A Lawrie; Marianne D van de Wetering; Leontien C M Kremer; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

4.  High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.

Authors:  Puneeta Tandon; Angela Delisle; Jeffrey E Topal; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-17       Impact factor: 11.382

5.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

6.  The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.

Authors:  Francesco Salerno; Mauro Borzio; Claudia Pedicino; Rosa Simonetti; Angelo Rossini; Sergio Boccia; Irene Cacciola; Andrew K Burroughs; Matteo A Manini; Vincenzo La Mura; Paolo Angeli; Mauro Bernardi; Daniela Dalla Gasperina; Elena Dionigi; Clara Dibenedetto; Milena Arghittu
Journal:  Liver Int       Date:  2016-07-22       Impact factor: 5.828

Review 7.  Novel prevention strategies for bacterial infections in cirrhosis.

Authors:  Kathleen Yan; Guadalupe Garcia-Tsao
Journal:  Expert Opin Pharmacother       Date:  2016-02-23       Impact factor: 3.889

8.  Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.

Authors:  Laura Turco; Guadalupe Garcia-Tsao; Ilenia Magnani; Marcello Bianchini; Martina Costetti; Cristian Caporali; Stefano Colopi; Emilio Simonini; Nicola De Maria; Federico Banchelli; Rosario Rossi; Erica Villa; Filippo Schepis
Journal:  J Hepatol       Date:  2018-01-10       Impact factor: 25.083

9.  Intestinal permeability determinants of norfloxacin in Ussing chamber model.

Authors:  Cassiana Mendes; Gabriela C Meirelles; Marcos A S Silva; Gilles Ponchel
Journal:  Eur J Pharm Sci       Date:  2018-05-31       Impact factor: 4.384

10.  Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

Authors:  Rajiv Jalan; Javier Fernandez; Reiner Wiest; Bernd Schnabl; Richard Moreau; Paolo Angeli; Vanessa Stadlbauer; Thierry Gustot; Mauro Bernardi; Rafael Canton; Agustin Albillos; Frank Lammert; Alexander Wilmer; Rajeshwar Mookerjee; Jordi Vila; Rita Garcia-Martinez; Julia Wendon; José Such; Juan Cordoba; Arun Sanyal; Guadalupe Garcia-Tsao; Vicente Arroyo; Andrew Burroughs; Pere Ginès
Journal:  J Hepatol       Date:  2014-02-12       Impact factor: 25.083
View more
  2 in total

1.  Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway.

Authors:  Alexander A Maini; Natalia Becares; Louise China; Thais H Tittanegro; Amit Patel; Roel P H De Maeyer; Nekisa Zakeri; Tu Vinh Long; Lucy Ly; Derek W Gilroy; Alastair O'Brien
Journal:  JHEP Rep       Date:  2021-08-04

Review 2.  Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients.

Authors:  Cyriac Abby Philips; Mohamed Rela; Arvinder Singh Soin; Subhash Gupta; Sudhindran Surendran; Philip Augustine
Journal:  J Clin Transl Hepatol       Date:  2021-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.